Page 30 - Study Co News Today

More than two years into the pandemic, multiple analyses of federal, state and local data show that people of color were, and continue to be, disproportionately impacted by COVID-19.

The majority of people living with Long Covid experience some form of stigma directly related to their condition, according to a new study published in the journal PLOS ONE.

Artificial intelligence is being used by researchers at the Department of Physical Education’s Human Movement Laboratory (Movi-Lab) at São Paulo State University (UNESP) in Bauru, Brazil, to assist in the diagnosis and prediction of the progression of Parkinson's disease.

Negotiation regarding a new Global Plastics Treaty has made the nations meet in Uruguay. Marine and forensic scientists reported new outcomes this week that disclose the breakthrough of synthetic plastic fibers in seawater, air, sea ice, and sediment sampled in the Antarctic Weddell Sea.

Researchers found that the North Atlantic gyre had much higher concentrations of plastic, which is made up of polymers derived from packaging, rope, and paint particles, when compared to other open ocean regions.

A promising new technology is the use of organic solar cells. They have the potential to be more attractive for urban or façade applications than the common silicon solar panel because they can be lightweight, flexible, and display a range of colors.

According to a recent ICTA-UAB study, switching to a low-carbon energy system could result in significant global emissions, consuming the majority of the carbon budget still available and leaving less emissions available for socioeconomic processes and activities.

According to a recent article in the Royal Society of Chemistry journal Materials Horizons, CSU researchers have developed the first successful soft robotic gripper capable of controlling individual droplets of liquid.

American transplant centers as well as organ procurement organizations, the groups responsible for recovering organs from deceased donors in the United States, were less likely to accept or select organs from donors who were 70 years old when they died compared to those who were 69, new research found.

Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed. Scientists have dubbed this type of targeted approach a "prodrug" -; a medicine designed to release its payload in a particular area of the body and in no other areas.